MYLAN LABORATORIES LTD.

NSE : NABSE : 524794ISIN CODE : INE604D01023Industry : Pharmaceuticals & DrugsHouse : MNC
BSE209.350 (0 %)
PREV CLOSE ( ) 209.35
OPEN PRICE ( ) 208.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 209.35 (2)
VOLUME 50392
TODAY'S LOW / HIGH ( )208.80 211.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2017Mar2016Mar2014Mar2013Mar2011
Profit Before Tax-6373.33-2275.5513515.138133.395890.43
Adjustment27911.6518439.131239.614481.161537.44
Changes In working Capital-5061.54-13358.48-8185.97-5872.37-3427.60
Cash Flow after changes in Working Capital16476.782805.106568.776742.184000.27
Cash Flow from Operating Activities16243.262561.763594.253579.202308.75
Cash Flow from Investing Activities-5686.63-57729.47-57963.24-8342.01-3652.81
Cash Flow from Financing Activities-9802.2755532.9654654.855009.271122.11
Net Cash Inflow / Outflow754.36365.25285.86246.46-221.95
Opening Cash & Cash Equivalents540.51175.31589.65309.62240.11
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-0.44-0.05NA33.57216.00
Closing Cash & Cash Equivalent1294.43540.51875.51589.65234.16

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.